Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase III Non-inferiority Study of Radiotherapy Plus Concurrent Nimotuzumab Versus Cisplatin in Stage II-III Nasopharyngeal Carcinoma

NCT03837808 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT03837808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03837808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase III Non-inferiority Study of Radiotherapy Plus Concurrent Nimotuzumab Versus Cisplatin in Stage II-III Nasopharyngeal Carcinoma
Lead sponsor
Sun Yat-sen University
Phase
Phase 3
Overall status
Unknown status
Start date
April 11, 2019
Completion date
February 11, 2024
Enrollment
384 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck neoplasm, nasopharyngeal carcinoma, nasopharyngeal diseases, nasopharyngeal neoplasms